NEW YORK (Reuters Health) – Insulin resistance substantially curbs the chances of a sustained viral response following standard treatment for chronic hepatitis C virus (HCV) infection, according to…
NEW YORK (Reuters Health) – Perinatal transmission of hepatitis B virus from highly viremic mothers to their offspring is substantially reduced with telbivudine therapy during pregnancy, without any…
NEW YORK (Reuters Health) – Ceftazidime and amikacin delivered by nebulizer is as effective as intravenous administration in treating ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, and is…
NEW YORK (Reuters Health) – The risk of progression to AIDS in HIV-infected patients is significantly reduced when combined antiretroviral therapy is started at a CD4 count threshold…
NEW YORK (Reuters Health) – Outcomes among tuberculosis patients treated with a fixed-dose combination of four drugs are similar to those in patients treated with the same four…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the importance of taking a holistic approach to AIDS work in Africa. For more information…
NEW YORK (Reuters Health) – The presence of low-frequency HIV-1 drug resistance mutations – especially against non-nucleoside reverse transcriptase inhibitors (NNRTIs) – confers a greater than twofold increased…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses new Anti-AIDS drug treatments available, including Anti-AIDS gels and Anti-AIDS preventative drugs. For more information…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses relevant statistics regarding AIDS in Africa and elsewhere. For more information on ICAMiA’s important work…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses his work with the Israel Consortium on AIDS Medicine in Africa (ICAMiA) and the importance…